The short answer: healthcare AI is stuck between insight and execution

Healthcare leaders no longer need convincing that AI can create value. The harder question is why so many AI insights still fail to influence daily decisions.

A recent Arcadia survey of 281 executives across provider, payer, and service organizations, conducted around HIMSS26, puts a number on the problem: 53% of AI-generated insights are only partially integrated into decision-making workflows, while only 14% of respondents report full integration at key decision points.

That is not a technology adoption gap. It is an operating model gap.

The survey also found that 52% of executives believe AI can transform healthcare when applied to the right use cases. Only 6% see AI as more dangerous than useful. In other words, the industry is not broadly rejecting AI. It is struggling to turn AI into repeatable behavior inside complex organizations.

The next phase of healthcare AI will not be won by organizations with the most impressive demos. It will be won by organizations that can convert probabilistic insight into governed, measurable, everyday action.

Why this matters to enterprise strategy

Healthcare is one of the clearest examples of why AI is not merely a technical matter. Clinical care, reimbursement, scheduling, patient engagement, claims, risk adjustment, staffing, and quality reporting all involve judgment. Many of these processes are not fully deterministic. They require interpretation, prioritization, and context.

That is exactly where AI can be valuable.

But this is also where AI can be dangerous if implemented shallowly. A model can identify a patient at high risk of readmission. That does not automatically mean the organization knows who should act, when they should act, which intervention should be triggered, how the action should be documented, or how impact should be measured financially and clinically.

Healthcare executives should therefore stop asking only whether a model is accurate. They should ask:

  • Where does this insight enter the workflow?
  • Who is accountable for reviewing or acting on it?
  • What decision does it improve?
  • What action is triggered if confidence is high?
  • What happens when the model is uncertain?
  • Which metric will prove that the process improved?

Without these answers, AI becomes another dashboard. Healthcare already has enough dashboards.

The four adoption blockers are telling

The survey identified four main barriers to responsible AI scaling: integration into daily decision-making, education for leaders and teams, stronger data infrastructure, and impact measurement.

Those are not separate problems. They are one chain.

If leaders do not understand how AI behaves, they will not redesign workflows around it. If workflows are not redesigned, the data infrastructure will be judged only by technical completeness rather than operational usefulness. If measurement is weak, finance teams will not trust the ROI story. If ROI is unclear, AI remains a budget line rather than a strategic capability.

This is why serious AI implementation requires a multidisciplinary approach. The strongest teams combine:

  • AI and data science knowledge
  • Clinical and operational expertise
  • Process design experience
  • Change management capability
  • Finance and performance measurement discipline
  • Governance, privacy, and security competence

Academic depth also matters. Healthcare AI cannot be built responsibly on LinkedIn slogans or generic prompt templates. The field requires an understanding of models, uncertainty, bias, clinical context, operational constraints, and management systems. There are many self-appointed AI experts, but in healthcare, shallow advice can create real operational and ethical damage.

Human in the loop is essential, but not enough

Healthcare organizations often respond to AI risk by adding a human review step. That is sensible. Human in the loop is one of the most important principles in responsible AI deployment, especially in clinical and administrative settings where decisions affect patients, staff, and reimbursement.

But there is a trap.

If every AI-supported process requires the same level of human effort as the original manual process, the organization has not transformed anything. It has simply added another layer of work.

The real design question is not whether a human should be involved. The real question is how one skilled professional who previously supervised one process can now supervise hundreds of AI-assisted processes safely and effectively.

That shift requires clear escalation logic:

  • Low-risk, high-confidence cases can be automated or batch-approved.
  • Medium-risk cases can be reviewed through structured queues.
  • High-risk or low-confidence cases must go to expert review.
  • Edge cases should be captured for learning and governance.
  • Exceptions should improve the system over time.

This is where AI creates operational leverage. It does not remove human judgment. It concentrates human judgment where it matters most.

Healthcare needs two AI tracks, not one

Many organizations treat AI adoption as a single program. That is a mistake. Healthcare organizations need to move on two tracks at the same time.

First, they need AI literacy across leadership, operations, clinical teams, finance, and information systems. People must learn how to communicate effectively with models, interpret AI outputs, challenge weak recommendations, and understand where AI is useful or inappropriate.

Second, they need an AI agent capability: the ability to design, deploy, monitor, and improve AI agents that execute defined tasks across systems.

These two tracks behave differently.

AI tools often require employees to change daily work habits. That can be harder than it looks. Even when a tool is technically simple, adoption may be slow because it asks people to write differently, search differently, summarize differently, or think differently.

AI agents can be technically more complex, but they may require less behavior change from frontline staff. A well-designed agent can sit behind a workflow and handle prior authorization preparation, care gap outreach preparation, revenue cycle follow-up, coding review support, or appointment capacity analysis without forcing every employee to become an AI power user.

This distinction is important for healthcare leaders. Adoption strategy should not be based only on technical difficulty. It should be based on organizational friction.

The coming role of information systems teams

In many enterprises, information systems departments are already changing. In healthcare, this will become especially visible. These teams will not only manage applications, integrations, permissions, and infrastructure. They will increasingly become a kind of human resources department for AI agents.

That means they will need to know:

  • Which agents exist in the organization
  • Who owns each agent
  • Which systems each agent can access
  • Which decisions each agent supports
  • How performance is monitored
  • How failures are escalated
  • When an agent should be retrained, revised, or retired

This requires an enterprise platform for rapid agent creation and governance. Microsoft Copilot Studio is a reasonable option for organizations deeply invested in the Microsoft ecosystem, especially where governance and identity management are already centered there. At the same time, tools such as n8n are entering serious enterprise environments and enabling more flexible automation patterns that would have seemed unlikely in large organizations a few years ago.

Model choice also matters, but it should not become a religious debate. Claude remains one of the strongest options for broad enterprise work because of its reasoning quality and practical usability, though security and data governance require careful attention. Microsoft Copilot is improving and benefits from deep enterprise distribution, even if innovation can feel slower in a large platform environment. OpenAI models remain strong and versatile. The right architecture may use several models, with governance deciding which model is appropriate for which task.

In healthcare, the architecture should serve the process, not the other way around.

What executives should do now

The Arcadia survey points toward a practical conclusion: healthcare organizations should invest less energy in isolated experimentation and more energy in AI operating discipline.

A serious healthcare AI program should start with a small number of decision points where value is measurable. Good candidates usually share three characteristics: high volume, meaningful cost or quality impact, and clear human accountability.

Examples include:

  • Reducing avoidable readmissions
  • Prioritizing care management outreach
  • Improving appointment utilization
  • Accelerating prior authorization workflows
  • Supporting revenue cycle exception handling
  • Identifying documentation gaps
  • Forecasting staffing pressure
  • Detecting financial leakage in payer-provider processes

For each use case, leaders should define the process before selecting the tool.

A practical implementation sequence looks like this:

  1. Select a decision point with measurable clinical, operational, or financial value.
  2. Map the current workflow, including handoffs and delays.
  3. Define the AI recommendation and the required confidence level.
  4. Decide where human review is mandatory and where automation is acceptable.
  5. Connect the AI output to the system where work actually happens.
  6. Train managers and users on interpretation, escalation, and accountability.
  7. Measure baseline performance before launch.
  8. Track cost, quality, cycle time, staff burden, and exception rates after launch.
  9. Review failures systematically and improve the workflow, not only the model.

This is not glamorous work. It is the work that separates enterprise AI from theater.

The Israeli healthcare angle

The same pattern is highly relevant in Israel. Health funds, hospitals, digital health units, and government-led healthcare initiatives have advanced data assets and strong technical capabilities. Israel also has a culture of practical innovation that can accelerate AI adoption.

But the risk is familiar: excellent pilots that do not become system-wide operating change.

Organizations such as major health funds and hospital networks can produce impressive AI proofs of concept. The real test is whether those systems become part of the daily rhythm of clinicians, administrators, finance teams, and patient service operations. That requires data quality, management education, privacy discipline, and clear measures of success.

Israel’s advantage is not only technical talent. It is the ability to bring clinicians, managers, researchers, and technologists into the same room. That multidisciplinary model is exactly what healthcare AI needs.

The financial case must become sharper

Healthcare executives in the survey expect AI to produce cost savings, reduce staff turnover, and improve financial forecasting. These are the right categories, but they must be translated into hard operational metrics.

For example, reducing staff turnover is not just an HR metric. It may be connected to documentation burden, schedule instability, manual claims work, repetitive patient communication, or constant exception handling. AI can help, but only if the organization identifies which tasks are causing friction and which workflows can be redesigned.

Similarly, cost savings should not be treated as a vague promise. Finance leaders should demand a clear bridge from AI activity to business outcome:

  • Fewer manual touches per claim
  • Shorter authorization cycle times
  • Better appointment fill rates
  • Lower readmission-related costs
  • Fewer denied claims
  • Better coding completeness
  • More accurate demand and staffing forecasts

AI budgets will face more scrutiny as experimentation matures. The organizations that can explain AI ROI in operational language will keep funding. The organizations that speak only about innovation will struggle.

The real lesson for 2026

The healthcare sector is not behind because it lacks ambition. It is behind because AI touches the hardest part of the enterprise: how decisions are made.

Models can generate insight. Agents can execute tasks. Tools can assist employees. But durable value comes from redesigned processes, educated managers, governed data, and measurable outcomes.

Healthcare leaders should treat AI as a management discipline, not a software feature. The winners will build internal capability, not dependency. They will train people, but also build agents. They will keep humans in the loop, but redesign the loop so one expert can safely oversee far more work than before.

That is the difference between having AI in the organization and becoming an AI-capable organization.